BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37750845)

  • 1. Machine learning identification of patient clusters for cutaneous melanoma.
    Thompson LJ; Furmanchuk A; Liszewski W; Kho A; West DP; Liebovitz DM; Nardone B; Gerami P
    Ital J Dermatol Venerol; 2023 Oct; 158(5):388-394. PubMed ID: 37750845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
    Fisher NM; Schaffer JV; Berwick M; Bolognia JL
    J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous malignant melanoma.
    Guill CK; Orengo I
    Dermatol Nurs; 2001 Jun; 13(3):210-3. PubMed ID: 11917455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of circumstances of diagnosis and access to dermatological care in early diagnosis of cutaneous melanoma: a population-based study in France.
    Durbec F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Domissy-Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A; Grange F
    Arch Dermatol; 2010 Mar; 146(3):240-6. PubMed ID: 20231493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Reminder of Skin Cancer During the COVID-19 Pandemic.
    Šitum M; Filipović N; Buljan M
    Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing trends in melanoma treatment and the expanding role of the dermatologist.
    Brown MD; Johnson TM; Swanson NA
    Dermatol Clin; 1991 Oct; 9(4):657-67. PubMed ID: 1934641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who detects melanoma? Impact of detection patterns on characteristics and prognosis of patients with melanoma.
    Avilés-Izquierdo JA; Molina-López I; Rodríguez-Lomba E; Marquez-Rodas I; Suarez-Fernandez R; Lazaro-Ochaita P
    J Am Acad Dermatol; 2016 Nov; 75(5):967-974. PubMed ID: 27645105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Melanoma-A Review in Detection, Staging, and Management.
    Hartman RI; Lin JY
    Hematol Oncol Clin North Am; 2019 Feb; 33(1):25-38. PubMed ID: 30497675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a 31-gene Expression Profiling Test for Cutaneous Melanoma on Dermatologists' Clinical Management Decisions.
    Farberg AS; Glazer AM; White R; Rigel DS
    J Drugs Dermatol; 2017 May; 16(5):428-431. PubMed ID: 28628677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of Skin Cancer Diagnosis by Physician Assistants Compared With Dermatologists in a Large Health Care System.
    Anderson AM; Matsumoto M; Saul MI; Secrest AM; Ferris LK
    JAMA Dermatol; 2018 May; 154(5):569-573. PubMed ID: 29710082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Care-Based Skin Cancer Screening in a Veterans Affairs Health Care System.
    Swetter SM; Chang J; Shaub AR; Weinstock MA; Lewis ET; Asch SM
    JAMA Dermatol; 2017 Aug; 153(8):797-801. PubMed ID: 28593242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agreement between dermatologists and primary care practitioners in the diagnosis of malignant melanoma: review of the literature.
    Corbo MD; Wismer J
    J Cutan Med Surg; 2012; 16(5):306-10. PubMed ID: 22971304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management.
    Ireland A; Millward M; Pearce R; Lee M; Ziman M
    Clin Exp Metastasis; 2011 Apr; 28(4):327-36. PubMed ID: 21311956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric patients with cutaneous melanoma: A European study.
    Brecht IB; De Paoli A; Bisogno G; Orbach D; Schneider DT; Leiter U; Offenmueller S; Cecchetto G; Godzinski J; Bien E; Stachowicz-Stencel T; Ben-Ami T; Chiaravalli S; Maurichi A; De Salvo GL; Sorbara S; Bodemer C; Garbe C; Reguerre Y; Ferrari A
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26974. PubMed ID: 29350487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating additional factors into the TNM staging for cutaneous melanoma by machine learning.
    Yang CQ; Wang H; Liu Z; Hueman MT; Bhaskaran A; Henson DE; Sheng L; Chen D
    PLoS One; 2021; 16(9):e0257949. PubMed ID: 34591891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of the clinical trial landscape for cutaneous melanoma.
    Perkins SH; Stensland KD; Galsky MD; Sivendran S
    Cutis; 2015 Sep; 96(3):186-90. PubMed ID: 26562269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Cutaneous Melanoma: the Gap Between the Knowledge of General Practitioners and Dermatologists in a Brazilian Population.
    Garrido AQ; Wainstein AJA; Brandão MPA; de Vasconcellos Santos FA; Bittencourt FV; Ledsham C; Drummond-Lage AP
    J Cancer Educ; 2020 Aug; 35(4):819-825. PubMed ID: 32193871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model.
    Vale L; Kunonga P; Coughlan D; Kontogiannis V; Astin M; Beyer F; Richmond C; Wilson D; Bajwa D; Javanbakht M; Bryant A; Akor W; Craig D; Lovat P; Labus M; Nasr B; Cunliffe T; Hinde H; Shawgi M; Saleh D; Royle P; Steward P; Lucas R; Ellis R
    Health Technol Assess; 2021 Nov; 25(64):1-178. PubMed ID: 34792018
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.